Glioblastoma is one of the most aggressive and challenging brain cancers that adults can face, growing rapidly and demanding immediate medical attention. This devastating disease starts in the brain’s supportive cells and can dramatically change someone’s life in just months. Understanding what glioblastoma is, how it affects the body, and what treatment options exist can help patients and families navigate this difficult journey with greater knowledge and preparation.

What Is Glioblastoma?

Glioblastoma is a type of cancer that begins in the brain or, less commonly, in the spinal cord. It develops from cells called astrocytes, which are star-shaped cells that normally support and protect nerve cells in the brain. These supportive cells are part of a larger family of cells known as glial cells, which perform essential functions like providing nutrients to neurons, maintaining protective barriers, and helping nerve cells communicate with each other.^[1][2]

This particular cancer is classified as a grade 4 tumor, which means it is the most aggressive type of brain tumor doctors encounter. The term “grade 4” indicates that the cancer cells look very different from normal, healthy cells when examined under a microscope, and they grow and multiply extremely quickly. Glioblastoma cells invade and destroy healthy brain tissue around them, spreading into nearby areas like tentacles reaching into the surrounding brain.^[2][4]

Previously, this cancer was called glioblastoma multiforme, but doctors now typically refer to it simply as glioblastoma or use the abbreviation GBM. The cancer can develop in different ways. Most cases are primary glioblastomas, which appear suddenly without any warning or lower-grade tumor beforehand. In contrast, secondary glioblastomas develop when a lower-grade brain tumor transforms over time into this more aggressive form. Patients with primary glioblastomas tend to be older and generally face a more challenging prognosis.^[5][12]

Epidemiology: How Common Is Glioblastoma?

Glioblastoma is the most common type of cancerous brain tumor in adults, accounting for approximately 15 to 16 percent of all primary brain tumors and about 47.7 percent of all malignant brain tumors in adults. Despite being relatively rare compared to other cancers, it has a significant impact on those it affects.^[4][5][6]

In the United States, approximately 3 in every 100,000 people develop glioblastoma each year. This translates to roughly 13,000 to 15,000 new diagnoses annually in the country. While these numbers might seem small compared to more common cancers like breast or lung cancer, glioblastoma represents a substantial burden because of its aggressive nature and poor survival rates.^[4][5][8]

The disease typically affects older adults, with the average age at diagnosis being 64 years. However, glioblastoma can occur at any age, including in children, though it is much less common in younger people. Men are more likely to develop this cancer than women, with the ratio being approximately 1.6 men for every 1 woman diagnosed. The disease also appears more frequently in Caucasians compared to other ethnic groups.^[2][4][5]

Glioblastomas typically develop in the cerebral hemispheres of the brain, which are the large, rounded structures that make up most of the brain’s mass. Specifically, about 61 percent of these tumors occur in the four main lobes: the frontal lobe (25%), temporal lobe (20%), parietal lobe (13%), and occipital lobe (3%). Less commonly, they can appear in the brain stem, cerebellum, or spinal cord.^[5][6][12]

Causes: Why Does Glioblastoma Develop?

The exact cause of most glioblastoma cases remains unknown, which makes prevention particularly challenging. Scientists believe that the disease develops when something goes wrong in the genetic instructions that tell brain cells how to grow and divide. These instructions are stored in DNA within our genes, and when mutations or changes occur in this DNA, cells can begin to multiply out of control, eventually forming a tumor.^[1][2]

Originally, researchers thought glioblastomas came only from glial cells, but evidence now suggests they may arise from multiple types of cells that have properties similar to neural stem cells. These cells exist at various stages of development, from stem cells to neurons to fully formed glial cells. The specific characteristics of each tumor seem to be determined more by molecular changes in signaling pathways within the cells rather than by the exact type of cell where the cancer started.^[5][12]

Advanced research, including the Cancer Genome Atlas project, has revealed that glioblastoma has an extremely complex genetic profile. Scientists have identified more than 600 different genes that can be altered in glioblastoma tumors, and they’ve found three core signaling pathways that are commonly disrupted in these cancers. These pathways normally control important cell functions like growth, division, and death, but when they malfunction, cancer can develop.^[5][12]

Risk Factors: Who Is More Likely to Develop Glioblastoma?

While the specific cause of glioblastoma is usually unclear, certain factors can increase a person’s likelihood of developing this cancer. Age is one of the most significant risk factors, with glioblastoma occurring most frequently in people between 45 and 70 years old. The median age at diagnosis is 64 years, though the disease can strike at any age.^[2][4]

Previous exposure to radiation, particularly therapeutic radiation to the head, is one of the few proven environmental risk factors for glioblastoma. People who received radiation therapy for other medical conditions, especially during childhood, have an elevated risk of developing brain tumors later in life. However, it’s important to note that the vast majority of people who receive therapeutic radiation do not develop glioblastoma.^[1][4]

Certain rare genetic disorders significantly increase the risk of developing glioblastoma. These include neurofibromatosis, a condition that causes tumors to grow on nerves throughout the body; Li-Fraumeni syndrome, which increases the risk of various cancers; Lynch syndrome, typically associated with colon cancer but also linked to brain tumors; and Turcot syndrome, which combines intestinal polyps with brain tumors. However, inherited glioblastomas are quite rare, and most cases occur randomly without any family history.^[1][4][6]

Some studies have suggested potential associations between glioblastoma and exposure to certain chemicals, including pesticides, petroleum products, synthetic rubber, and vinyl chloride. Research has also indicated that factors like decreased susceptibility to allergies and impaired immune response might be associated with increased risk, though these connections are not fully understood and require more research.^[2][6]

Symptoms: How Does Glioblastoma Affect People?

The symptoms of glioblastoma can vary greatly depending on where the tumor is located in the brain and how large it has grown. Initially, symptoms may be nonspecific and easily mistaken for other, less serious conditions. This is one reason why diagnosis can sometimes be delayed, as early signs might not immediately suggest a brain tumor.^[1][4]

Many symptoms occur because the growing tumor takes up space inside the skull, which has a fixed volume. As the tumor expands, it puts pressure on healthy brain tissue, causing what doctors call increased intracranial pressure. This pressure can also build up when the tumor blocks the normal flow of cerebrospinal fluid, the liquid that cushions and protects the brain and spinal cord. Additionally, swelling around the tumor can further contribute to increased pressure inside the skull.^[15]

Headaches are among the most common symptoms, particularly those that are persistent and tend to be worse in the morning. These headaches might become progressively more severe over time. Patients often experience nausea and vomiting, which can occur with or without headache. Some people notice changes in their vision, such as blurred vision, double vision, or loss of peripheral (side) vision.^[1][2][15]

Because different parts of the brain control different functions, the location of the tumor determines many of the specific symptoms a person experiences. For example, a tumor near the motor cortex, which controls movement, might cause weakness or loss of sensation on one side of the body. Tumors affecting language areas can lead to difficulty speaking or understanding speech. Problems with balance and coordination might occur if the tumor affects areas that control these functions.^[1][15]

Cognitive and behavioral changes are also common. These can include confusion, problems with memory, difficulty thinking clearly or processing information, personality changes, irritability, and mood swings. Some people experience a general decline in brain function that affects their ability to perform daily activities. New-onset seizures, meaning seizures in someone who has never had them before, are another important warning sign that should prompt immediate medical evaluation.^[1][2][8]

A concerning feature of glioblastoma symptoms is that they often worsen rapidly. Unlike some conditions where symptoms develop gradually over months or years, glioblastoma symptoms can progress quickly, sometimes over just weeks. In severe cases, symptoms can advance to unconsciousness if the tumor is not treated. The rapid worsening of symptoms is often what prompts people to seek emergency medical care.^[4]

Prevention: Can Glioblastoma Be Prevented?

Unfortunately, there is currently no known method to prevent glioblastoma. Because the exact causes of most cases remain unclear, and because the disease typically develops without warning or identifiable triggers, doctors cannot recommend specific prevention strategies the way they might for cancers linked to lifestyle factors like smoking or sun exposure.^[4][10]

The lack of prevention options underscores the importance of recognizing symptoms early and seeking prompt medical evaluation. While you cannot prevent glioblastoma, being aware of warning signs and acting quickly when symptoms appear can help ensure the earliest possible diagnosis and treatment. Early intervention may provide more treatment options and potentially better outcomes, even though the disease remains extremely challenging to treat.^[1]

For people with known genetic conditions that increase brain tumor risk, such as neurofibromatosis or Li-Fraumeni syndrome, regular monitoring and follow-up with healthcare providers may be recommended. However, even in these cases, there are no proven strategies to prevent tumors from developing; monitoring simply allows for earlier detection if a tumor does appear.^[4]

Pathophysiology: How Glioblastoma Changes the Brain

Understanding how glioblastoma affects the brain requires looking at both the physical changes the tumor causes and the disruptions it creates in normal brain function. At the cellular level, glioblastoma represents uncontrolled proliferation, meaning the cancer cells divide and multiply much faster than normal cells and ignore the usual signals that tell cells when to stop growing or to die.^[7]

Cancer cells, including those in glioblastoma, exhibit what scientists call the “hallmarks of cancer.” These include sustaining signals that promote growth, evading growth suppressors that normally limit cell division, resisting cell death (a process called apoptosis that usually removes damaged or unnecessary cells), enabling unlimited cell division (most normal cells can only divide a limited number of times), inducing the formation of new blood vessels to supply the tumor (angiogenesis), and generating inflammation that actually helps the tumor rather than fighting it.^[7]

One of the particularly challenging features of glioblastoma is how the cancer cells invade surrounding brain tissue. Unlike some tumors that grow as a distinct mass with clear boundaries, glioblastoma cells send out finger-like projections that infiltrate deep into normal brain tissue. This invasive growth pattern makes it nearly impossible to remove all cancer cells through surgery alone, as microscopic tumor cells often remain in the brain even after surgeons have removed all visible tumor tissue.^[2][11]

The tumor often disrupts the blood supply to surrounding brain tissue. While glioblastomas are highly vascular, meaning they develop extensive networks of blood vessels to feed their rapid growth, these vessels are typically abnormal. They leak fluid into the surrounding brain tissue, causing swelling known as peritumoral edema. This swelling compounds the pressure problems inside the skull and can cause additional symptoms. The abnormal blood vessels also make it difficult for chemotherapy drugs to reach the tumor effectively, as the irregular blood flow creates an inconsistent drug delivery.^[6]

Another important feature of glioblastoma pathophysiology is tumor heterogeneity, meaning the tumor contains many different types of cells with varying characteristics. Within a single tumor, different cell populations may respond differently to treatment, which helps explain why glioblastomas are so resistant to therapy. Some cells may be killed by chemotherapy while others survive and continue growing, leading to tumor recurrence. Scientists have identified three broad subtypes of glioblastoma based on molecular features, though even within these subtypes there is considerable variation.^[7]

The presence of cancer stem cells in glioblastomas is another factor that makes these tumors so difficult to eliminate. These cells have properties similar to normal stem cells, including the ability to self-renew and give rise to many different cell types. Cancer stem cells are particularly resistant to standard treatments and are thought to play a key role in tumor recurrence after treatment.^[7]

At the molecular level, glioblastomas are characterized by specific genetic changes. Modern classification of these tumors relies heavily on molecular markers rather than just appearance under the microscope. For example, glioblastomas typically do not have mutations in genes called IDH1 or IDH2, which is why they are classified as “IDH-wildtype” tumors. They often have other genetic changes, such as mutations in the TERT gene, alterations in the EGFR gene, or abnormalities in chromosomes 7 and 10. These molecular features help doctors predict how the tumor might behave and guide treatment decisions.^[9][15]